Literature DB >> 28507759

Emerging local ablative therapies for unresectable perihilar cholangiocarinoma: Time for re-appraisal.

Pim B Olthof1, Robert J Coelen1, Michal Heger1, Heinz-Josef Klümpen2, Erik A Rauws2, Thomas M van Gulik1.   

Abstract

Year:  2017        PMID： 28507759      PMCID： PMC5415217          DOI： 10.1177/2050640616686857

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  10 in total

1.  Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.

Authors:  Young Koog Cheon; Tae Yoon Lee; Seung Min Lee; Jung Yoon Yoon; Chan Sup Shim
Journal:  HPB (Oxford)       Date:  2012-01-06       Impact factor: 3.647

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.

Authors:  Andrej Wagner; Ulrike W Denzer; Daniel Neureiter; Tobias Kiesslich; Andreas Puespoeck; Erik A J Rauws; Klaus Emmanuel; Nora Degenhardt; Ulrich Frick; Ulrich Beuers; Ansgar W Lohse; Frieder Berr; Gernot W Wolkersdörfer
Journal:  Hepatology       Date:  2015-07-22       Impact factor: 17.425

4.  Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.

Authors:  Thomas Zoepf; Ralf Jakobs; Joachim C Arnold; Darius Apel; Jürgen F Riemann
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

5.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

6.  Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.

Authors:  B Groot Koerkamp; J K Wiggers; M Gonen; A Doussot; P J Allen; M G H Besselink; L H Blumgart; O R C Busch; M I D'Angelica; R P DeMatteo; D J Gouma; T P Kingham; T M van Gulik; W R Jarnagin
Journal:  Ann Oncol       Date:  2015-06-30       Impact factor: 32.976

7.  Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.

Authors:  A Schmidt; M Bloechinger; A Weber; J Siveke; S von Delius; C Prinz; W Schmitt; R M Schmid; B Neu
Journal:  United European Gastroenterol J       Date:  2016-02-03       Impact factor: 4.623

8.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.

Authors:  Marianne E J Ortner; Karel Caca; Frieder Berr; Jochen Liebetruth; Ulrich Mansmann; Dominik Huster; Winfried Voderholzer; Guido Schachschal; Joachim Mössner; Herbert Lochs
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

9.  Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients.

Authors:  Anthony T Ruys; Steven van Haelst; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

10.  The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.

Authors:  Hester J Scheffer; Jantien A Vogel; Willemien van den Bos; Robert E Neal; Krijn P van Lienden; Marc G H Besselink; Martin J C van Gemert; Cees W M van der Geld; Martijn R Meijerink; John H Klaessens; Rudolf M Verdaasdonk
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240
  10 in total
  1 in total

1.  Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid.

Authors:  Lianne R de Haan; Joanne Verheij; Rowan F van Golen; Verena Horneffer-van der Sluis; Matthew R Lewis; Ulrich H W Beuers; Thomas M van Gulik; Steven W M Olde Damink; Frank G Schaap; Michal Heger; Pim B Olthof
Journal:  Biomolecules       Date:  2021-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.